Home | Site Map | Contact Us

NYRx, the Medicaid Pharmacy Program

Notifications

Notifications

Provider Notifications
Date Title
12/21/22 Pharmacy Billing Guidance Exceptions for Non-Enrolled Prescribers in Medicaid
11/08/22 Policy and Billing Guidance for Pharmacy Reimbursement of COVID-19 Oral Antivirals as of November 8, 2022
10/31/22 Retroactive Lump Sum Payment for the Increased Pharmacy Dispensing Fee
10/18/22 Medicaid Pharmacy Prior Authorization Programs Update - Effective November 17, 2022
09/21/22 Pharmacy Professional Dispensing Fee Update Effective September 22, 2022
09/21/22 New York State Medicaid Policy and Billing Guidance for Pharmacy Reimbursement of COVID-19 Oral Antivirals
09/21/22 New York State Medicaid Pharmacy Coverage of Polio Vaccine Effective September 9, 2022 through October 9, 2022
08/23/22 Practitioner Administered Drug Update: New York State Medicaid Fee-for-Service Policy Guidance for esketamine (SPRAVATO®) nasal spray
07/11/22 Medicaid Pharmacy Prior Authorization Programs Update - Effective August 11, 2022
05/24/22 Attention: The Utilization Threshold Program has been revised effective July 1, 2022
02/15/22 Updated Guidance: Statewide Formulary for Opioid Dependence Agents and Opioid Antagonists
02/08/22 Preferred Diabetic Supply Program Update
02/07/22 Medicaid Pharmacy Prior Authorization Programs Update - Effective March 22, 2022
01/14/22 Attention Pharmacy Providers - Important Information Regarding Inhaled Corticosteroids in Children
11/22/21 Clozapine Risk Evaluation and Mitigation Strategy (REMS) Certain Program Requirements Temporarily Suspended
10/15/21 Attention Medicaid Fee-for Service (FFS) Providers: Brand Less than Generic Update-Suboxone Film
10/07/21 Clozapine Risk Evaluation and Mitigation Strategy Requires Providers and Pharmacies to Re-certify/Re-enroll Patients by November 15, 2021
10/04/21 Statewide Formulary for Opioid Dependence Agents and Opioid Antagonists - New Information
09/29/21 Medicaid Pharmacy Prior Authorization Programs Update - Effective October 28, 2021
09/22/21 Clozapine Risk Evaluation and Mitigation Strategy Requires Providers and Pharmacies to Re-certify and Re-enroll Patients by November 15, 2021
Get Adobe Reader

You will need Adobe® Reader to view any printable PDF document(s).
Click the button to the left to download a free copy of Adobe® Reader.